Alaunos Therapeutics is an oncology-focused cell therapy company developing adoptive T-cell receptor (TCR) therapies, designed to treat various solid tumor types in cancer patient. Co. is utilizing its cancer mutation hotspot TCR library and its proprietary, non-viral Sleeping Beauty genetic engineering technology to design and manufacture patient-specific cell therapies that target neoantigens arising from tumor-related mutations in main oncogenic genes, including KRAS, TP53 and EGFR. Co. evaluates TCRs reactive to mutated KRAS, TP53 and EGFR from its TCR library for the investigational treatment of non-small cell lung, colorectal, endometrial, pancreatic, ovarian and bile duct cancers. We show 9 historical shares outstanding datapoints in our TCRT shares outstanding history coverage, used to compute TCRT market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing TCRT market cap history over the course of time is important for investors
interested in comparing TCRT's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of TCRT versus a peer is one thing; comparing
TCRT market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like TCRT can fluctuate over the course of history.
With this page we aim to empower investors researching TCRT by allowing them to research the TCRT market cap history. |
Free TCRT Email Alerts:
Video: The Importance of Market Cap
